New RAS-mutant pancreatic adenocarcinoma with combined BRAF and MEK inhibition for metastatic melanoma

Carlino, M.S. et al. (2015) New RAS-mutant pancreatic adenocarcinoma with combined BRAF and MEK inhibition for metastatic melanoma. Journal of Clinical Oncology, 33(11), e52-e56. (doi:10.1200/JCO.2013.51.5783) (PMID:24821886)

Full text not currently available from Enlighten.

Abstract

No abstract available.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Biankin, Professor Andrew
Authors: Carlino, M.S., Kwan, V., Miller, D.K., Saunders, C.A.B., Yip, D., Nagrial, A.M., Tomlinson, J., Grimmond, S.M., Scolyer, R.A., Kefford, R.F., Biankin, A.V., and Long, G. V.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cancer Sciences
Journal Name:Journal of Clinical Oncology
Journal Abbr.:J. Clin. Oncol.
Publisher:American Society of Clinical Oncology
ISSN:0732-183X
ISSN (Online):1527-7755

University Staff: Request a correction | Enlighten Editors: Update this record